281 related articles for article (PubMed ID: 21083328)
21. [Improvement of a multi-target screening analysis for drugs using a QTRAP liquid chromatography/tandem mass spectrometry system].
Miyagi H; Kajiwara M; Onishi H; Yamaguchi Y; Watanabe T
Rinsho Byori; 2007 Apr; 55(4):309-18. PubMed ID: 17511260
[TBL] [Abstract][Full Text] [Related]
22. Detecting and characterizing reactive metabolites by liquid chromatography/tandem mass spectrometry.
Ma S; Subramanian R
J Mass Spectrom; 2006 Sep; 41(9):1121-39. PubMed ID: 16967439
[TBL] [Abstract][Full Text] [Related]
23. Ternary-column system for high-throughput direct-injection bioanalysis by liquid chromatography/tandem mass spectrometry.
Xia YQ; Whigan DB; Powell ML; Jemal M
Rapid Commun Mass Spectrom; 2000; 14(2):105-11. PubMed ID: 10623938
[TBL] [Abstract][Full Text] [Related]
24. Addressing the challenge of limited sample volumes in in vitro studies with capillary-scale microfluidic LC-MS/MS.
Rainville PD; Smith NW; Wilson ID; Nicholson JK; Plumb RS
Bioanalysis; 2011 Apr; 3(8):873-82. PubMed ID: 21510761
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of LC-MS/MS method for the determination of cyproheptadine in several pharmaceutical syrup formulations.
Feás X; Ye L; Hosseini SV; Fente CA; Cepeda A
J Pharm Biomed Anal; 2009 Dec; 50(5):1044-9. PubMed ID: 19574011
[TBL] [Abstract][Full Text] [Related]
26. Chiral liquid chromatography-tandem mass spectrometric methods for stereoisomeric pharmaceutical determinations.
Chen J; Korfmacher WA; Hsieh Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jun; 820(1):1-8. PubMed ID: 15866486
[TBL] [Abstract][Full Text] [Related]
27. Strategies in quantitative LC-MS/MS analysis of unstable small molecules in biological matrices.
Li W; Zhang J; Tse FL
Biomed Chromatogr; 2011 Jan; 25(1-2):258-77. PubMed ID: 21204113
[TBL] [Abstract][Full Text] [Related]
28. Turbulent flow bioanalysis in drug metabolism and pharmacokinetics.
Rudewicz PJ
Bioanalysis; 2011 Jul; 3(14):1663-71. PubMed ID: 21756098
[TBL] [Abstract][Full Text] [Related]
29. Bioanalysis of an oligonucleotide and its metabolites by liquid chromatography-tandem mass spectrometry.
Deng P; Chen X; Zhang G; Zhong D
J Pharm Biomed Anal; 2010 Aug; 52(4):571-9. PubMed ID: 20153130
[TBL] [Abstract][Full Text] [Related]
30. Pharmaceutical trace analysis in aqueous environmental matrices by liquid chromatography-ion trap tandem mass spectrometry.
Madureira TV; Barreiro JC; Rocha MJ; Cass QB; Tiritan ME
J Chromatogr A; 2009 Oct; 1216(42):7033-42. PubMed ID: 19748099
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the use of UPLC-TOFMS with simultaneous [14C]-radioflow detection for drug metabolite profiling: application to propranolol metabolites in rat urine.
Athersuch TJ; Sison RL; Kenyon AS; Clarkson-Jones JA; Wilson ID
J Pharm Biomed Anal; 2008 Sep; 48(1):151-7. PubMed ID: 18571352
[TBL] [Abstract][Full Text] [Related]
32. Tandem mass spectrometry (LC-MS-MS): a predominant role in bioassays for pharmacokinetic studies.
Marzo A; Bo LD
Arzneimittelforschung; 2007; 57(2):122-8. PubMed ID: 17396623
[TBL] [Abstract][Full Text] [Related]
33. Multi-residue method for trace level determination of pharmaceuticals in solid samples using pressurized liquid extraction followed by liquid chromatography/quadrupole-linear ion trap mass spectrometry.
Jelić A; Petrović M; Barceló D
Talanta; 2009 Nov; 80(1):363-71. PubMed ID: 19782237
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive multi-residue method for the target analysis of pesticides in crops using liquid chromatography-tandem mass spectrometry.
Hiemstra M; de Kok A
J Chromatogr A; 2007 Jun; 1154(1-2):3-25. PubMed ID: 17442324
[TBL] [Abstract][Full Text] [Related]
35. Outsource-ability of high-resolution MS-based DMPK assays.
Rago B; Negahban A
Bioanalysis; 2016 Aug; 8(16):1641-4. PubMed ID: 27416917
[No Abstract] [Full Text] [Related]
36. Analysis of polar metabolites by hydrophilic interaction chromatography--MS/MS.
Jian W; Xu Y; Edom RW; Weng N
Bioanalysis; 2011 Apr; 3(8):899-912. PubMed ID: 21510763
[TBL] [Abstract][Full Text] [Related]
37. Integrating qualitative and quantitative liquid chromatography/tandem mass spectrometric analysis to support drug discovery.
Poon GK; Kwei G; Wang R; Lyons K; Chen Q; Didolkar V; Hop CE
Rapid Commun Mass Spectrom; 1999; 13(19):1943-50. PubMed ID: 10487941
[TBL] [Abstract][Full Text] [Related]
38. A simple liquid chromatography-tandem mass spectrometry method to determine relative plasma exposures of drug metabolites across species for metabolite safety assessments.
Gao H; Deng S; Obach RS
Drug Metab Dispos; 2010 Dec; 38(12):2147-56. PubMed ID: 20847138
[TBL] [Abstract][Full Text] [Related]
39. Novel strategies for microdose studies using non-radiolabeled compounds.
Maeda K; Sugiyama Y
Adv Drug Deliv Rev; 2011 Jun; 63(7):532-8. PubMed ID: 21345359
[TBL] [Abstract][Full Text] [Related]
40. Novel generic UPLC/MS/MS method for high throughput analysis applied to permeability assessment in early Drug Discovery.
Mensch J; Noppe M; Adriaensen J; Melis A; Mackie C; Augustijns P; Brewster ME
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 847(2):182-7. PubMed ID: 17095304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
